Presentation TCT 2024 A Closer Look at the ACURATE IDE Study Presenter: Michael J. Reardon October 30, 2024
Presentation TCT 2024 TCT 961: Immune Thrombocytopenic Purpura Is an Independent Risk Factor for Prosthetic Aortic Valve Degeneration: Analysis of the National Inpatient Sample Database 2019 Presenter: Palak R. Patel October 30, 2024
Presentation TCT 2024 Optimizing TAVI Through Standardized Invasive Hemodynamics Presenter: Ravi Ramana October 30, 2024
Presentation TCT 2024 One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial Presenter: Michael J. Reardon October 30, 2024
Presentation TCT 2024 Prediction of In-Hospital Mortality Following TAVI Using the FRANCE-TAVI Registry: A Machine Learning Approach Presenter: Walid Ben-Ali October 30, 2024
Presentation TCT 2024 TCT 839: Optimal Blood Pressure Targets for Aortic Valve Replacement Patients Presenter: Brennan Vogl October 29, 2024
Presentation TCT 2024 TCT 842: TAVR in ESRD: Short- and Long-Term Outcomes, Valve Degeneration and Reintervention Rates in Propensity-Matched Analysis Presenter: Samuel Gregerson October 29, 2024
Presentation TCT 2024 TCT 125: Predictors of Pathological Electrophysiological Study Post-TAVI: Focusing on Changes in PR and QRS Intervals Presenter: Paula Vela Martin October 29, 2024
Presentation TCT 2024 My Most Important Lessons Learned from Unusual Aortic Disease Challenges Presenter: Oscar A. Mendiz October 29, 2024
Presentation TCT 2024 TCT 904: Trends and Outcomes of Mechanical Circulatory Support With Transcatheter Valve Intervention From the National Inpatient Sample (2017-2020) Presenter: Omar Sami Abdelhai October 29, 2024